Cybin Inc
Change company Symbol lookup
Select an option...
CYBN Cybin Inc
FAZE FaZe Holdings Inc
AYTU Aytu Biopharma Inc
WFC Wells Fargo & Co
XOM Exxon Mobil Corp
URBF Urban Barns Foods Inc
ETO Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
FMS Fresenius Medical Care AG & Co KGaA
JNJ Johnson & Johnson
MYTE MYT Netherlands Parent BV
Go


Based in Canada
Company profile

Cybin Inc. is a Canada-based biotechnology company. The Company is focused on progressing Psychedelics to therapeutics by engineering drug discovery platforms, drug delivery systems, formulation approaches and treatment regimens for mental health disorders. Across the various research and development programs, the Company is researching and developing an array of synthetic psychedelic active pharmaceutical ingredients (API) intended to be delivered through drug delivery systems, including sublingual films1, orally disintegrating tablets (ODT)2, via inhalation and via intravenous (IV). Its drug programs include Depressive Disorder (CYB003), Alcohol Use Disorder (CYB003), Anxiety Disorders (CYB004) and Neuroinflammation (CYB005). The Company focuses on the clinical development path for CYB004, the Company's deuterated Phase 1 N,N-dimethyltryptamine (DMT) molecule, for the treatment of anxiety disorders. Its subsidiaries include Cybin Corp., Natures Journey Inc, and others.

The symbol you entered, CLXPF, changed to CYBN.

Postmarket

Last Trade
Delayed
$0.60
-0.0009 (-0.15%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$0.6009
Day's Change
-0.039 (-6.09%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.6476
Day's Low
0.59
Volume
(Light)
Volume:
656,678

10-day average volume:
1,051,201
656,678
  • Prev Close
    0.6399
  • Today's Open
    0.6432
  • Day's Range
    0.59-0.6476
  • Avg Vol (10-day)
    1.1M
  • Last (time)
    4:10p ET 10/07/22
  • Last (size)
    737
  • 52-Wk Range
    0.3903 - 2.36
    LowHigh
  • (11/05/21 - 05/13/22)
    53.96%
  • 81.2%
  • Market Cap
    99.8M
  • Shares Outstanding
    166.1M
  • -0.38
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 13.07
  • (% of float 09/15/22)
    3.92

Latest News

October 06, 2022
8:00 am ET
BusinessWire
September 27, 2022
8:00 am ET
BusinessWire
7:30 am ET
Globe Newswire
September 21, 2022
8:00 am ET
BusinessWire
September 20, 2022
8:00 am ET
BusinessWire
September 07, 2022
8:50 am ET
PR Newswire
August 31, 2022
8:00 am ET
BusinessWire
August 30, 2022
8:00 am ET
BusinessWire
August 25, 2022
8:00 am ET
BusinessWire
August 17, 2022
8:00 am ET
BusinessWire
August 15, 2022
5:05 pm ET
BusinessWire
August 10, 2022
8:50 am ET
PR Newswire
August 08, 2022
8:17 pm ET
BusinessWire
5:22 pm ET
BusinessWire
5:07 pm ET
BusinessWire
July 28, 2022
8:00 am ET
BusinessWire
July 27, 2022
8:45 am ET
PR Newswire
July 25, 2022
4:01 pm ET
BusinessWire
July 12, 2022
8:00 am ET
BusinessWire
July 11, 2022
7:30 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.